Back to discover
Disease
MODY
Active therapeutic pipeline
Also known as Maturity-onset diabetes of the young.
1
Clinical trials
12
Associated genes
2
Related proteins
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 1 clinical trial expected to report results, the earliest in Q3 2027.
Major developments
Upcoming trial readoutImportant
Results expected Q3 20272025-12-23
Clinical MilestonesViewHide
Results expected
- 2025-12-23Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 DiabetesResults expected Q3 2027
Activity timeline1
- 2025-12-23ClinicalCardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 DiabetesResults expected Q3 2027
Clinical trials
The current development programme across all trial phases.
Clinical programme
1
1
0
0
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
Synonyms
Maturity-onset diabetes of the young
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Related entities are derived from literature co-mention (studied together) — associative, not causal.